Company registration number 12121743 (England and Wales)
KKG PHARMA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
KKG PHARMA LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
£
£
£
£
Fixed assets
11,358
-
0
Current assets
87,101
60,442
Creditors: amounts falling due within one year
(149,058)
(148,503)
Net current liabilities
(61,957)
(88,061)
Total assets less current liabilities
(50,599)
(88,061)
Net liabilities
(50,599)
(88,061)
Capital and reserves
(50,599)
(88,061)
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year wa s as follows:

2026
2025
Number
Number
Employees
6
5
KKG PHARMA LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2026
31 March 2026
- 2 -

KKG Pharma Limited is a private company limited by shares incorporated in England and Wales. The registered office is K L Pharmacy, 1-2 Tyler Road, Southall, England, UB2 4XQ.

For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 July 2026 and are signed on its behalf by:
B Roopra
Director
Company Registration Number 12121743
2026-03-31 2025-04-01 false false CCH Software CCH Accounts Production 2026.100 No description of principal activity B Roopra J Gorae-Midha false 12121743 2025-04-01 2026-03-31 12121743 2026-03-31 12121743 2025-03-31 12121743 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 12121743 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 12121743 2024-04-01 2025-03-31 12121743 bus:Director1 2025-04-01 2026-03-31 12121743 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 12121743 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 12121743 bus:Micro-entities 2025-04-01 2026-03-31 12121743 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 12121743 bus:Director2 2025-04-01 2026-03-31 12121743 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP